New drug trial offers hope for painful skin condition
NCT ID NCT07170917
Summary
This study is testing an investigational drug called brivekimig for people with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin condition. It aims to see if different doses of the drug can safely reduce painful skin lumps and tunnels and improve quality of life. About 208 participants will receive either the drug or a placebo for up to 48 weeks to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR Clinical South Strand, South Carolina- Site Number : 8400018
RECRUITINGMyrtle Beach, South Carolina, 29588, United States
-
Advanced Medical Research - Atlanta- Site Number : 8400011
RECRUITINGAtlanta, Georgia, 30342, United States
-
Alfred Hospital - Site Number: 0360002
RECRUITINGMelbourne, Victoria, 3004, Australia
-
Alpine Research Association- Site Number : 8400008
RECRUITINGLayton, Utah, 84041, United States
-
Clinical Partners- Site Number : 8400002
RECRUITINGJohnston, Rhode Island, 02919, United States
-
FXM Clinical Research - Miami- Site Number : 8400017
RECRUITINGMiami, Florida, 33175, United States
-
FXM Clinical Research Miramar, LLC - Site Number: 8400004
RECRUITINGMiramar, Florida, 33027, United States
-
Georgia Skin & Cancer Clinic- Site Number : 8400009
RECRUITINGSavannah, Georgia, 31419, United States
-
Interior Dermatology Centre - Site Number: 1240003
RECRUITINGKelowna, British Columbia, V1W 4V5, Canada
-
Investigational Site Number : 1240009
RECRUITINGToronto, Ontario, M4E 1R7, Canada
-
Investigational Site Number : 1560001
RECRUITINGGuangzhou, 510018, China
-
Investigational Site Number : 1560002
RECRUITINGChengdu, 610041, China
-
Investigational Site Number : 2500006
RECRUITINGSaint-Priest-en-Jarez, 42270, France
-
Investigational Site Number : 2760001
RECRUITINGMünster, 48149, Germany
-
Investigational Site Number : 2760003
RECRUITINGFrankfurt, 60590, Germany
-
Investigational Site Number : 2760005
RECRUITINGKiel, 24105, Germany
-
Investigational Site Number : 2760008
RECRUITINGBramsche, 49565, Germany
-
Investigational Site Number : 3480004
RECRUITINGSzékesfehérvár, 8000, Hungary
-
Investigational Site Number : 5280002
RECRUITINGGroningen, 9713 GR, Netherlands
-
Investigational Site Number : 7240007
RECRUITINGGranada, 18014, Spain
-
Investigational Site Number : 8260006
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
Investigational Site Number : 8260008
RECRUITINGLondon, England, E1 1BB, United Kingdom
-
Investigational Site Number: 0360001
RECRUITINGLiverpool, New South Wales, 2170, Australia
-
Investigational Site Number: 1240005
RECRUITINGQuébec, Quebec, G1W 4R4, Canada
-
Investigational Site Number: 1520001
RECRUITINGSantiago, Reg Metropolitana de Santiago, 8380465, Chile
-
Investigational Site Number: 1520002
RECRUITINGSantiago, Reg Metropolitana de Santiago, 7640881, Chile
-
Investigational Site Number: 1520003
RECRUITINGSantiago, Reg Metropolitana de Santiago, 7580206, Chile
-
Investigational Site Number: 1520005
RECRUITINGSantiago, Reg Metropolitana de Santiago, 8420383, Chile
-
Investigational Site Number: 2030001
RECRUITINGPrague, 110 00, Czechia
-
Investigational Site Number: 2030002
RECRUITINGOstrava, 702 00, Czechia
-
Investigational Site Number: 2030003
RECRUITINGOstrava, 708 52, Czechia
-
Investigational Site Number: 2030004
RECRUITINGPrague, 150 06, Czechia
-
Investigational Site Number: 2500001
RECRUITINGAntony, 92160, France
-
Investigational Site Number: 2500004
RECRUITINGBezannes, 51430, France
-
Investigational Site Number: 2500007
RECRUITINGToulouse, 31059, France
-
Investigational Site Number: 3760001
RECRUITINGTel Aviv, 6423906, Israel
-
Investigational Site Number: 3760002
RECRUITINGJerusalem, 9112001, Israel
-
Investigational Site Number: 3800002
RECRUITINGMilan, Milano, 20122, Italy
-
Investigational Site Number: 6160001
RECRUITINGWroclaw, Lower Silesian Voivodeship, 50-566, Poland
-
Investigational Site Number: 6160002
RECRUITINGWarsaw, Masovian Voivodeship, 02-507, Poland
-
Investigational Site Number: 6160003
RECRUITINGLodz, Lódzkie, 90-265, Poland
-
Investigational Site Number: 7240001
RECRUITINGMadrid, 28046, Spain
-
Investigational Site Number: 7240002
RECRUITINGManises, Valencia, 46940, Spain
-
Investigational Site Number: 7240003
RECRUITINGLas Palmas de Gran Canaria, Las Palmas, 35010, Spain
-
Investigational Site Number: 7240004
RECRUITINGCadiz, 11009, Spain
-
Investigational Site Number: 7240005
RECRUITINGMadrid, 28007, Spain
-
Investigational Site Number: 7240006
RECRUITINGSantiago de Compostela, A Coruña [La Coruña], 15706, Spain
-
Istituto Dermatologico San Gallicano, IRCCS - Site Number : 3800004
RECRUITINGRoma, 00144, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lima's Excellence in Allergy and Dermatology Research (LEADER) Inc.
RECRUITINGHamilton, Ontario, L8L 3C3, Canada
-
Louisiana Dermatology Associates- Site Number : 8400006
RECRUITINGBaton Rouge, Louisiana, 70809, United States
-
Meiwa Hospital
RECRUITINGNishinomiya, Hyōgo, 663-8186, Japan
-
Nihon University Itabashi Hospital
RECRUITINGTokyo, 173-8610, Japan
-
Northridge Clinical Trials - Northridge- Site Number : 8400005
RECRUITINGNorthridge, California, 91325, United States
-
University of the Ryukyus Hospital - Site Number: 3920002
RECRUITINGNishihara, Okinawa, 903-0215, Japan
Conditions
Explore the condition pages connected to this study.